137 related articles for article (PubMed ID: 27802896)
1. Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline-A study using zebrafish model.
Nathan JR; Lakshmanan G; Michael FM; Seppan P; Ragunathan M
Biomed Pharmacother; 2016 Dec; 84():1406-1418. PubMed ID: 27802896
[TBL] [Abstract][Full Text] [Related]
2. Targeting expression of adenosine receptors during hypoxia induced angiogenesis - A study using zebrafish model.
Panneerselvan N; Ragunathan M
Biomed Pharmacother; 2018 Mar; 99():101-112. PubMed ID: 29329032
[TBL] [Abstract][Full Text] [Related]
3. Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.
Kim BH; Lee J; Choi JS; Park DY; Song HY; Park TK; Cho CH; Ye SK; Joo CK; Koh GY; Kim TY
Br J Pharmacol; 2015 Aug; 172(15):3875-89. PubMed ID: 25917462
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity.
Wu YC; Chang CY; Kao A; Hsi B; Lee SH; Chen YH; Wang IJ
PLoS One; 2015; 10(5):e0126750. PubMed ID: 25978439
[TBL] [Abstract][Full Text] [Related]
5. von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish.
van Rooijen E; Voest EE; Logister I; Bussmann J; Korving J; van Eeden FJ; Giles RH; Schulte-Merker S
Dis Model Mech; 2010; 3(5-6):343-53. PubMed ID: 20335444
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
Kamran MZ; Gude RP
Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
[TBL] [Abstract][Full Text] [Related]
7. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells.
Takagi H; King GL; Robinson GS; Ferrara N; Aiello LP
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2165-76. PubMed ID: 8843903
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and anti-angiogenicity evaluation of Pak1 inhibitor IPA-3 using zebrafish embryo model.
Jagadeeshan S; Sagayaraj RV; Paneerselvan N; Ghouse SS; Malathi R
Cell Biol Toxicol; 2017 Feb; 33(1):41-56. PubMed ID: 27581547
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
11. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype.
Feoktistov I; Ryzhov S; Zhong H; Goldstein AE; Matafonov A; Zeng D; Biaggioni I
Hypertension; 2004 Nov; 44(5):649-54. PubMed ID: 15452028
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
14. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre-miR-21 and VEGF.
Merrigan SL; Kennedy BN
Br J Pharmacol; 2017 Aug; 174(16):2636-2651. PubMed ID: 28547797
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy.
Cao R; Jensen LD; Söll I; Hauptmann G; Cao Y
PLoS One; 2008 Jul; 3(7):e2748. PubMed ID: 18648503
[TBL] [Abstract][Full Text] [Related]
17. Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia.
Ryzhov S; McCaleb JL; Goldstein AE; Biaggioni I; Feoktistov I
J Pharmacol Exp Ther; 2007 Feb; 320(2):565-72. PubMed ID: 17132813
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
Takagi H; King GL; Ferrara N; Aiello LP
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
[TBL] [Abstract][Full Text] [Related]
19. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.
Rezzola S; Paganini G; Semeraro F; Presta M; Tobia C
Biochim Biophys Acta; 2016 Jul; 1862(7):1291-6. PubMed ID: 27085972
[TBL] [Abstract][Full Text] [Related]
20. In vitro and ex vivo retina angiogenesis assays.
Rezzola S; Belleri M; Gariano G; Ribatti D; Costagliola C; Semeraro F; Presta M
Angiogenesis; 2014 Jul; 17(3):429-42. PubMed ID: 24121991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
